Literature DB >> 9187198

Revisions in the International System for Staging Lung Cancer.

C F Mountain1.   

Abstract

Revisions in stage grouping of the TNM subsets (T=primary tumor, N=regional lymph nodes, M=distant metastasis) in the International System for Staging Lung Cancer have been adopted by the American Joint Committee on Cancer and the Union Internationale Contre le Cancer. These revisions were made to provide greater specificity for identifying patient groups with similar prognoses and treatment options with the least disruption of the present classification: T1N0M0, stage IA; T2N0M0, stage IB; T1N1M0, stage IIA; T2N1M0 and T3N0M0, stage IIB; and T3N1M0, T1N2M0, T2N2M0, T3N2M0, stage IIIA. The TNM subsets in stage IIIB-T4 any N M0, any T N3M0, and in stage IV-any T any N M1, remain the same. Analysis of a collected database representing all clinical, surgical-pathologic, and follow-up information for 5,319 patients treated for primary lung cancer confirmed the validity of the TNM and stage grouping classification schema.

Entities:  

Mesh:

Year:  1997        PMID: 9187198     DOI: 10.1378/chest.111.6.1710

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  693 in total

1.  Results of surgery for primary lung cancer based on the new international staging system.

Authors:  T Koike; M Terashima; T Takizawa; T Aoki; T Watanabe; H Akamatsu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-07

Review 2.  Is there a role for adjuvant therapy for resected non-small cell lung cancer?

Authors:  J R Jett
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

3.  Screening for lung cancer: can it be cost-effective?

Authors:  O S Miettinen
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

4.  BTS guidelines: guidelines on the selection of patients with lung cancer for surgery.

Authors: 
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 5.  Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.

Authors:  J Britton
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

6.  Atrial resection in advanced lung carcinoma under total cardiopulmonary bypass.

Authors:  E R Ferguson; M J Reardon
Journal:  Tex Heart Inst J       Date:  2000

7.  Does immunointensity account for the differences in prognostic significance of Bcl-2 expression in non-small cell lung cancer?

Authors:  G Cox; R A Walker; S Muller; K R Abrams; W P Steward; K J O'Byrne
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

8.  Tumor-associated macrophages in stage IIIA pN2 non-small cell lung cancer after neoadjuvant chemotherapy and surgery.

Authors:  Po-Hao Feng; Chih-Teng Yu; Chin-Yang Wu; Meng-Jung Lee; Wei-Hwa Lee; Liang-Shun Wang; Shu-Min Lin; Jen-Fen Fu; Kang-Yun Lee; Tzung-Hai Yen
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

9.  Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Daniela Chindamo; Michele Bertoni; Emanuele Cassarà; Carlo Salvarani
Journal:  Ann Rheum Dis       Date:  2007-09-03       Impact factor: 19.103

Review 10.  State of the art in thoracospic surgery: a personal experience of 2000 videothoracoscopic procedures and an overview of the literature.

Authors:  G C Roviaro; F Varoli; C Vergani; M Maciocco
Journal:  Surg Endosc       Date:  2002-02-28       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.